CDX2 and cholangiocarcinoma: In practice, immunohistochemical detection of CK-7, CK-19, CK-20, CDX-2, and CA199 biomarkers is often used to identify CCA [12,174]; whilst CK-7 and CAM5.2 biomarkers are strongly expressed in CCA cells.